{
    "ticker": "FLGV",
    "name": "Fulgent Genetics, Inc.",
    "description": "Fulgent Genetics, Inc. is a comprehensive genetic testing company that offers a wide range of genetic testing solutions for both clinical and research applications. Founded in 2011, Fulgent has positioned itself as a leader in the field of genomics by providing innovative and customizable testing services that enable healthcare providers to better diagnose and manage patient conditions. The company specializes in a variety of genetic tests, including next-generation sequencing (NGS), hereditary cancer testing, and infectious disease testing. Fulgent's advanced technology platform allows for rapid turnaround times and high-quality results, making it a preferred choice for both physicians and patients. The company's mission is to enhance healthcare through genetic insights, ultimately improving patient outcomes and advancing precision medicine. Additionally, Fulgent is dedicated to expanding access to genetic testing and fostering collaborations with healthcare institutions and researchers. With a focus on innovation, Fulgent continues to invest in research and development to expand its testing capabilities and maintain its competitive edge in the rapidly evolving field of genetics.",
    "industry": [
        "Genetics",
        "Healthcare"
    ],
    "headquarters": "Temple City, California, USA",
    "founded": "2011",
    "website": "https://www.fulgentgenetics.com",
    "ceo": "Ming Hsieh",
    "social_media": {
        "twitter": "https://twitter.com/FulgentGenetics",
        "linkedin": "https://www.linkedin.com/company/fulgent-genetics"
    },
    "investor_relations": "https://ir.fulgentgenetics.com",
    "key_executives": [
        {
            "name": "Ming Hsieh",
            "position": "CEO"
        },
        {
            "name": "Hao Zhang",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Genetic Testing",
            "products": [
                "Next-Generation Sequencing Tests",
                "Hereditary Cancer Panels",
                "Infectious Disease Testing"
            ]
        }
    ],
    "seo": {
        "meta_title": "Fulgent Genetics, Inc. | Comprehensive Genetic Testing Solutions",
        "meta_description": "Explore Fulgent Genetics, Inc. for innovative genetic testing solutions. Learn about our advanced technology and commitment to precision medicine.",
        "keywords": [
            "Fulgent Genetics",
            "Genetic Testing",
            "Next-Generation Sequencing",
            "Precision Medicine",
            "Healthcare Innovation"
        ]
    },
    "faq": [
        {
            "question": "What does Fulgent Genetics specialize in?",
            "answer": "Fulgent Genetics specializes in comprehensive genetic testing solutions, including next-generation sequencing and hereditary cancer testing."
        },
        {
            "question": "Who is the CEO of Fulgent Genetics?",
            "answer": "Ming Hsieh is the CEO of Fulgent Genetics, Inc."
        },
        {
            "question": "Where is Fulgent Genetics headquartered?",
            "answer": "Fulgent Genetics is headquartered in Temple City, California, USA."
        },
        {
            "question": "What types of tests does Fulgent offer?",
            "answer": "Fulgent offers next-generation sequencing tests, hereditary cancer panels, and infectious disease testing."
        },
        {
            "question": "When was Fulgent Genetics founded?",
            "answer": "Fulgent Genetics was founded in 2011."
        }
    ],
    "competitors": [
        "NTRA",
        "GHDX",
        "ILMN"
    ],
    "related_stocks": [
        "AMGN",
        "GILD",
        "REGN",
        "BMY"
    ]
}